Experimental RNA Drug Shows Promise for Repairing DNA and Healing Tissue Damage
TY1, a synthetic RNA drug developed by Cedars-Sinai, enhances DNA repair by boosting immune cell activity to reduce scarring and aid healing in heart attacks and autoimmune diseases.
8 Articles
8 Articles
Experimental RNA treatment shows surprising DNA repair power
Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore injured tissue. The discovery came from studying tiny molecular messages released by heart cells that naturally support healing after injury. By identifying and recreating the most powerful of these messages, the team developed a synthetic RNA molecule that boosts the body’s DNA-repair system, reduces scarring, and may impro…
Experimental RNA drug shows promise for repairing DNA and healing tissue damage
Cedars-Sinai scientists have developed an experimental drug that repairs DNA and serves as a prototype for a new class of medications that fix tissue damage caused by heart attack, inflammatory disease or other conditions.
First-ever drug to repair DNA and regenerate damaged tissue is here
After two decades in the making, scientists have cracked the code on a drug that can repair DNA, setting the scene for a new class of therapeutics that can fix tissue damage that occurs through heart attack, inflammatory disease and other conditions.Continue ReadingCategory: Heart Disease, Illnesses and conditions, Body and MindTags: Cedars-Sinai, Johns Hopkins Medicine, Heart attack, RNA, DNA, Exosomes, Chronic illness, Heart Failure, Heart Dis…
Experimental RNA drug helps hearts heal after heart attacks
A heart attack does more than block blood flow. Inside your body, it unleashes chaos. Heart cells flood with harmful oxygen molecules. DNA strands snap. Protein-making systems fail. Immune alarms roar to life. In hours, heart tissue begins to die. Days later, inflammation hardens into scar tissue. Over time, the heart weakens and may fail. Now, scientists say a tiny piece of synthetic RNA could change that story. In a study published in Science …
Experimental RNA drug repairs DNA and heals tissue
Cedars-Sinai scientists have unveiled TY1, an experimental drug designed to repair DNA damage, marking a significant advancement in medical therapeutics. Detailed in a publication in Science Translational Medicine, TY1 is positioned as a prototype for a new class of medications aimed at addressing tissue damage resulting from heart attacks, inflammatory diseases, and other conditions. “By probing the mechanisms of stem cell therapy, we discovere…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium






